Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:7,691Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,406Price:--
-
Mar 06, 2024 (filed on Mar 07, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-252Price:$49.25
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,030Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,644Price:--
-
Mar 06, 2024 (filed on Mar 07, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-309Price:$49.25
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Chacon Quiros Juan JoseOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:19,236Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Chacon Quiros Juan JoseOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:13,519Price:--
-
Jan 07, 2024 (filed on Mar 05, 2024)Insider Name:Slotkin BryanOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:296Price:$26.91
-
Dec 31, 2023 (filed on Jan 08, 2024)Insider Name:Custin AnnOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,496Price:$25.89
Filings by filing date
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:7,691Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,406Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,030Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,644Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Chacon Quiros Juan JoseOwnership Type:Direct OwnershipSecurities:Stock Option (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:19,236Price:--
-
Mar 06, 2024 (filed on Mar 19, 2024)Insider Name:Chacon Quiros Juan JoseOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:13,519Price:--
-
Mar 06, 2024 (filed on Mar 07, 2024)Insider Name:Mansbach Samuel RossOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-252Price:$49.25
-
Mar 06, 2024 (filed on Mar 07, 2024)Insider Name:Denhoy RajOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-309Price:$49.25
-
Jan 07, 2024 (filed on Mar 05, 2024)Insider Name:Slotkin BryanOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:296Price:$26.91
-
Dec 31, 2023 (filed on Jan 08, 2024)Insider Name:Custin AnnOwnership Type:Direct OwnershipSecurities:Common SharesNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,496Price:$25.89
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | Building B15 And 25 Coyol Free Zone ALAJUELA VG1110 |
Tel: | 1-415-8281044 |
Website: | https://establishmentlabs.com |
IR: | See website |
Key People | ||
Juan Jose Chacon Quiros Chief Executive Officer, Director | Rajbir S. Denhoy Chief Financial Officer | Roberto De Mezerville Chief Technology Officer | S. Ross Mansbach Chief Compliance Officer, General Counsel |
Business Overview |
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. |
Financial Overview |
For the fiscal year ended 31 December 2023, Establishment Labs Holdings Inc revenues increased 2% to $165.2M. Net loss increased 4% to $78.5M. Revenues reflect Europe segment increase of 65% to $80.2M, Other segment increase from $994K to $2.2M. Higher net loss reflects Sales, general and administrative increase of 16% to $133.5M (expense), Research and development increase of 34% to $24.2M (expense). |
Employees: | 908 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,530M as of Dec 31, 2023 |
Annual revenue (TTM): | $165.15M as of Dec 31, 2023 |
EBITDA (TTM): | -$61.03M as of Dec 31, 2023 |
Net annual income (TTM): | -$78.50M as of Dec 31, 2023 |
Free cash flow (TTM): | -$113.06M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $148.70M as of Dec 31, 2023 |
Shares outstanding: | 27,205,003 as of Mar 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |